Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community Study

September 3, 2017 at 6:54 pm

Open Forum Infectious Diseases April 2017 V.4 N.2

Sara Tomczyk; Seema Jain; Anna M Bramley; Wesley H Self; Evan J Anderson …

Background

Community-acquired pneumonia (CAP) 2007 guidelines from the Infectious Diseases Society of America (IDSA)/American Thoracic Society (ATS) recommend a respiratory fluoroquinolone or beta-lactam plus macrolide as first-line antibiotics for adults hospitalized with CAP. Few studies have assessed guideline-concordant antibiotic use for patients hospitalized with CAP after the 2007 IDSA/ATS guidelines. We examine antibiotics prescribed and associated factors in adults hospitalized with CAP.

Methods

From January 2010 to June 2012, adults hospitalized with clinical and radiographic CAP were enrolled in a prospective Etiology of Pneumonia in the Community study across 5 US hospitals. Patients were interviewed using a standardized questionnaire, and medical charts were reviewed. Antibiotics prescribed were classified according to defined nonrecommended CAP antibiotics. We assessed factors associated with nonrecommended CAP antibiotics using logistic regression.

Results

Among enrollees, 1843 of 1874 (98%) ward and 440 of 446 (99%) ICU patients received ≥1 antibiotic ≤24 hours after admission. Ward patients were prescribed a respiratory fluoroquinolone alone (n = 613; 33%), or beta-lactam plus macrolide (n = 365; 19%), beta-lactam alone (n = 240; 13%), among other antibiotics, including vancomycin (n = 235; 13%) or piperacillin/tazobactam (n = 157; 8%) ≤24 hours after admission. Ward patients with known risk for healthcare-associated pneumonia (HCAP), recent outpatient antibiotic use, and in-hospital antibiotic use <6 hours after admission were significantly more likely to receive nonrecommended CAP antibiotics.

Conclusions

Although more than half of ward patients received antibiotics concordant with IDSA/ATS guidelines, a number received nonrecommended CAP antibiotics, including vancomycin and piperacillin/tazobactam; risk factors for HCAP, recent outpatient antibiotic, and rapid inpatient antibiotic use contributed to this. This hypothesis-generating descriptive epidemiology analysis could help inform antibiotic stewardship efforts, reinforces the need to harmonize guidelines for CAP and HCAP, and highlights the need for improved diagnostics to better equip clinicians.

PDF

https://watermark.silverchair.com/api/watermark?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAdgwggHUBgkqhkiG9w0BBwagggHFMIIBwQIBADCCAboGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMDYIVnpr-z1CRBqorAgEQgIIBixnHl6eqWdaZ9CZ7wTRmvTjD6a6x5vX03U52NtyGN_eRbk6K5A8JoDC_8YOl-F3DFUVvCdrM2tlefJZwRSteEGpcn1_xcbjNlNlTwC-Gl9H0OONkgFG-AvcYnRwOngyTGQkbjNhFzNMyHdvAXJRwVJ2FcQK1VS5OqQSyiArwXU-bN5lCnu-WE2HFdSp0GYFFsFRXBmZNLK6gK_R10k7lTlUTcyq8QEkQ_4QvqQjodxS1CzcLZAdPYjinVqHA9o0CcsBiPFJK9WrzYIc83ks_CVwRLgdV21jV9xscgn1xyRT0hiRzSqufjqWfBp4v0oMJE48W-NdnUKEfYpiTSsGoOY9pzT72__mDUX-Gr_pziS5IkErNt8OPcHyM9s465HQbpWz_8xejx31KwWXddlmHxGTtJ8b8GbRzRK0HvN-xEREcpgYDuKw5B1FLsXUrp-tEvuwdyeA5TSzfK9QwSCX1TTpTaj63XNSq_igGOaZUu-_z_joU6TopoTcBv4Yo-kqAlZC9DkTT4lRuHhEz

Advertisements

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Infecciones respiratorias, Inmunizaciones, Metodos diagnosticos, Sepsis, Update.

Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis


Calendar

September 2017
M T W T F S S
« Aug   Oct »
 123
45678910
11121314151617
18192021222324
252627282930  

Most Recent Posts


%d bloggers like this: